Global Inclusion & Diversity Report - Bristol Myers Squibb
The contents of this website offer a sample of key accomplishments from our 2021 Global Inclusion & Diversity Report.
See below links to download full report PDF files.
| English | 繁體中文 (Chinese – Traditional) | 简体中文 (Chinese – Simplified) | Français (French) |
| 日 本語 (Japanese) | 한 국어(Korean) | Español (Spanish) | Рycckий (Russian) |
| Português do Brasil (Brazilian Portuguese) | Nederlands (Dutch) | Deutsch (German) | Italiano (Italian) |
Inclusion & Diversity strengthen the I.D. and foundation of Bristol Myers Squibb
We are guided by a single vision —
Transforming Patients' Lives Through Science
To fully realize this vision, we have relied on the strength of our rich history and long-standing commitment to inclusion and diversity to ensure that we can drive meaningful impact and outcomes for our patients and communities, our colleagues, and our business and industry.
Our evolved Global Inclusion & Diversity strategy and priorities are the first steps on that path forward.
Bristol Myers Squibb and the Bristol Myers Squibb Foundation: Inclusion & Diversity impact by the numbers
Global executive gender parity
45.5%
of global executives were women in 2021 vs. 42.6% in 2020
Diversity in clinical trials: Bringing clinical trials to diverse communities
54%
of U.S. clinical trial sites were located in highly diverse communities in 2021
Addressing health disparities in the U.S.
$27.9M
across 107 grants was awarded to support the health disparity efforts of non-profit organizations and external partners in 2021
Black/African American U.S. executive*
4.5%
of U.S. executives were Black/African American in 2021 vs. 2.4% in 2020
Latino/Hispanic U.S. executive*
7.2%
of U.S. executives were Latino/Hispanic in 2021 vs. 4.2% in 2020
Asian American U.S. executive*
17.7%
of U.S. executives were Asian American in 2021 vs. 16.7% in 2020
*Vice President or higher
Supplier diversity spending
$899M
in spending with diverse businesses in 2021 vs. $695M in 2020
Supplier diversity spending
45%
growth in supplier diversity spending between 2019 and 2021
Bristol Myers Squibb Foundation Diversity in Clinical Trials Award Program
52
scholars selected through the Bristol Myers Squibb Foundation's Robert A. Winn Diversity in Clinical Trials Award Program
Bristol Myers Squibb Foundation Diversity in Clinical Trials Award Program
73%
of Robert A. Winn Diversity in Clinical Trial scholars come from groups underrepresented in medicine
Bristol Myers Squibb Foundation Employee Giving Program
$802K
awarded to social justice organizations (September 2020 – December 2021)
*Bristol Myers Squibb donates to the Bristol Myers Squibb Foundation, an independent charitable organization.
Our Value of Inclusion circles the globe
We are guided by a single vision — transforming patients’ lives through science. To fully realize this vision, we have relied on the strength of our rich history and long-standing commitment to inclusion and diversity to ensure that we can drive meaningful impact and outcomes for our patients and communities, our colleagues, and our business and industry. Our evolved Global Inclusion & Diversity strategy and priorities are the first steps on that path forward.
Leading with our Value of Inclusion: Global Inclusion & Diversity refreshed strategy
Our Global Inclusion & Diversity strategy has three pillars focused on critically important stakeholders.
Drive innovation & growth to address the unmet needs of our increasingly diverse patients and communities around the world.
Lead with our Value of Inclusion to advance a workplace where our colleagues feel they belong, and their unique perspectives are valued and rewarded, while building a global workforce that reflects the diverse cultures, backgrounds and experiences of our patients and communities globally.
Reimagine and transform business and industry practices, processes and policies to achieve equitable advancement and outcomes for all.
The journey continues — Inclusion leading the way
We are proud of our company’s commitment to Inclusion & Diversity and the meaningful steps we are taking to drive equitable advancement and outcomes for all. Our collaborative efforts to foster inclusion require transparency across our organization. We want our workforce, partners and patients to be aware of our culture of inclusion and the commitment we have for continued growth in service to our patients around the world.